NDC 51655-492 – Glyburide
Glyburide 5 mg/1 · Tablet · Oral
Product NDC51655-492
Product details
- Brand name
- Glyburide
- Generic name
- Glyburide
- Labeler
- Northwind Health Company, LLC
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA090937
- Marketed since
- January 7, 2021
- Listing expires
- December 31, 2027
- Pharmacologic class
- Sulfonylurea
Active ingredients
- Glyburide 5 mg/1
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 51655-492-25 | 60 TABLET in 1 BOTTLE, PLASTIC (51655-492-25) | Feb 9, 2022 |
| 51655-492-26 | 90 TABLET in 1 BOTTLE, PLASTIC (51655-492-26) | Nov 16, 2023 |
| 51655-492-52 | 30 TABLET in 1 BOTTLE, PLASTIC (51655-492-52) | Jan 7, 2021 |
Other Glyburide products
- 50090-7408 Glyburide 2.5 mg/1 · Tablet · A-S Medication Solutions
- 50090-7859 Glyburide 5 mg/1 · Tablet · A-S Medication Solutions
- 50090-6607 Glyburide 5 mg/1 · Tablet · A-S Medication Solutions
- 50090-6196 Glyburide 5 mg/1 · Tablet · A-S Medication Solutions
- 50090-0495 Glyburide 5 mg/1 · Tablet · A-S Medication Solutions
- 50090-5776 Glyburide 2.5 mg/1 · Tablet · A-S Medication Solutions
- 71335-0069 Glyburide 2.5 mg/1 · Tablet · Bryant Ranch Prepack
- 71335-2771 Glyburide 5 mg/1 · Tablet · Bryant Ranch Prepack
- 71335-0150 Glyburide 5 mg/1 · Tablet · Bryant Ranch Prepack
- 71209-009 Glyburide 1.25 mg/1 · Tablet · Cadila Pharmaceuticals Limited
- 71209-010 Glyburide 2.5 mg/1 · Tablet · Cadila Pharmaceuticals Limited
- 71209-011 Glyburide 5 mg/1 · Tablet · Cadila Pharmaceuticals Limited